New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

"Our research demonstrates the power of GLP-1 therapies to transform health outcomes, with especially promising results for ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...

Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance ...

From weight loss injections to a newly approved pill, GLP-1 medications are everywhere– but many people are still unclear on ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

Oprah Winfrey uncovered the exact number on the scale that ignited her weight-loss journey. During the Tuesday, January 13, ...